|
Refine your search within these categories: |
C13. Female Urogenital Diseases and Pregnancy Complications (group results) |
|
C15. Hemic and Lymphatic Diseases: all > Lymphatic Diseases [MESH:D008206] |
|
C16. Congenital, Hereditary, and Neonatal Diseases and Abnormalities (group results) |
|
C21. Disorders of Environmental Origin |
|
D06. Hormones, Hormone Substitutes, and Hormone Antagonists (group results) |
|
E. Analytical, Diagnostic and Therapeutic Techniques and Equipment (group results) |
|
I. Anthropology, Education, Sociology and Social Phenomena |
|
|
|
Recently Viewed Items |
Go to Item History |
|
|
|
|
These terms define your current search. Click the ×
to remove a term.
C15. Hemic and Lymphatic Diseases: Lymphatic Diseases [MESH:D008206] |
×
|
D03. Heterocyclic Compounds: Heterocyclic Compounds [MESH:D006571] |
×
|
|
(others) (1) |
MESH:C570037
| N-(2-(diethylamino)ethyl)-2-methyl-7-(1,2-dihydro-5-fluoro-2-oxo-3H-indol-3 -ylidene)-4,5,6,7-tetrahydro-1H-indole-3-carboxamide C570037 | | | | | | | |
|
|
|
|